logo
Interstellar Visitor Zipping Through Our Solar System Could Be a Hostile Probe, Alien-Hyping Scientists Warn

Interstellar Visitor Zipping Through Our Solar System Could Be a Hostile Probe, Alien-Hyping Scientists Warn

Gizmodo5 days ago
There's a visitor in town, and its name is 3I/ATLAS. The presumed interstellar comet presents a rare opportunity for astronomers to study an object born a long time ago in a star system far, far away. But a new paper uploaded to the preprint arXiv server asks an intriguing question: Is the object actually alien technology?
For Harvard astronomer and study co-author Abraham Loeb, this is not his first interstellar rodeo. In 2018, Loeb proposed that the interstellar object 'Oumuamua might be an alien probe. He's now back at it, along with co-authors Adam Hibberd and Adam Crowl from the UK's Initiative for Interstellar Studies, asking the same question about 3I/ATLAS.
The team is essentially flagging 3I/ATLAS as a candidate for alien technology and, perhaps alarmingly, as something that might actually pose an existential threat to humanity. Sounds absolutely bonkers, but it's a topic worth exploring and not something to reflexively toss onto the garbage heap.
From the moment it entered our view, 3I/ATLAS—the third interstellar object ever detected in our solar system—instantly became the biggest news in astronomy for the month, if not the year. Astronomers are using the rare opportunity to study the object in as much detail as possible using the best instruments available. A clear picture of the object is emerging, suggesting it's very likely an enormous, icy comet that's considerably older than our solar system; preliminary estimates suggest it's 0.74 miles long (1.2 kilometers) and dates back some 7 billion years.
An Interstellar Comet Is Here, and Its Age Is Mind-Bending
The interstellar interloper is zipping through our solar system at ludicrous speeds, clocking in at 37 miles (60 kilometers) per second. Its velocity is so extreme that it'll exit our solar system and disappear from our view later this year, escaping the gravitational influence of our Sun. Astronomers are therefore under a tight deadline to understand everything they possibly can about 3I/ATLAS—an object that originated in some faraway protoplanetary or planetary system.
That said, astronomers have already made some great strides in sketching out the finer details of 3I/ATLAS, quickly churning out papers pertaining to the visitor's age, size, velocity, spin, and, most importantly, its origin, based on observational data. According to research released earlier this week, the object is a jumble of organic molecules, silicates, and carbon-based minerals, placing it in a similar compositional category as asteroids found between Mars and Jupiter.
Based on current data—much of it from researchers working with the newly launched Vera C. Rubin Observatory—3I/ATLAS is expected to pass through the asteroid belt between Mars and Jupiter later this fall, reaching its closest point to the Sun in late October. Excitingly, the Sun's warmth should sublimate enough ice on the comet to brighten the coma and tail even further.
Suffice it to say, astronomers' ongoing investigations into 3I/ATLAS largely confirm that it's a cometary castaway. Like other comets we've seen before, 3I/ATLAS likely emerged from natural processes and was banished to interstellar space by some gravitational interaction, such as a close encounter with a gigantic planet or a passing star. Importantly, and despite strange, unfounded claims made in the new Loeb paper, there's zero indication that 3I/ATLAS is anything but a natural object formed by natural processes.
Yet that hasn't stopped Loeb and his colleagues from venturing beyond the existing evidence. What's more, they've violated Occam's razor—a central tenet of the scientific method. Scientists are told that the simplest explanation is often the best when tackling puzzling phenomena. In this case, the simplest explanation, given the existing evidence, is that 3I/ATLAS is a comet. Often, when astronomers detect something unusual or inexplicable in space, there's the urge to invoke extraterrestrial influence.
The Many, Many Times Astronomers Mistook Mundane Phenomena for Aliens
This seems to be the case here, but as we'll discuss next, these researchers are not wrong to be asking these sorts of questions. As Sara Webb, an astrophysicist at the Swinburne University of Technology, wrote in The Conversation, 'Objects like 3I/ATLAS remind us that space is vast, strange, and full of surprises. Most of them have natural explanations. But the strangest objects are worth a second look.'
Loeb and his colleagues do bring up a salient point—that we need to be curious about this object and not simply assume that it is what we think it is. Moreover, the team's warning that this object, should it be an alien probe, poses a potential hostile threat to humanity is rooted in some fascinating—if not disturbing—philosophical arguments having to do with our failed search for signs of extraterrestrial intelligence.
The first is the Fermi Paradox—the surprising observation that, despite our galaxy's immense size and extreme age, we have yet to see any signs of intelligent aliens. As Italian physicist Enrico Fermi famously asked in 1950, 'Where is everybody?' This conundrum, known as the Great Silence, is not so easy to brush aside, as virtually all proposed solutions fail to convincingly account for the conspicuous absence of a Milky Way filled with extraterrestrials and extraterrestrial technology.
This has led a number of philosophers, astrobiologists, and science-fiction writers to propose some rather grim solutions to the Fermi Paradox, that is, solutions that point to a galaxy devoid of space-faring civilizations. Loeb's new paper invokes one of these solutions, an idea known as the Dark Forest hypothesis. The term is borrowed from sci-fi author Liu Cixin, who made note of this possibility in his The Three-Body Problem trilogy, specifically the 2008 novel The Dark Forest.
In Liu's imagined universe, intelligent civilizations stay silent and hidden because any interaction with aliens could be fatal; since it's impossible to know another civilization's intentions, the safest move is to eliminate potential threats before they can act. Hence, a Dark Forest galaxy, in which advanced civilizations take the form of silent hunters.
This general concept didn't start with Liu; sci-fi novelist and SETI expert David Brin has been ruminating over the possibility of killer alien probes since 1983.
As Loeb and his colleagues argue in the new paper, 3I/ATLAS, should it be artificial, is likely to possess 'active intelligence.' If that's the case, the object might be friendly, evil, or possibly something in between, they write. If it's benign, we can relax, but it's the second possibility—that it's malign—that's cause for 'most concern.' That's because the Dark Forest resolution to the Fermi Paradox is the more likely scenario, 'as it would neatly explain the singular lack of success of the SETI initiative to-date,' according to the paper.
In other words, the reason we have yet to encounter aliens is that they're stealthy hunters, and this interstellar visitor, should it be a probe, likely belongs to that class of civilizations. Which is obviously not good for us. This argument brings the Berserker probe concept to mind, an idea proposed by another science fiction writer, Fred Saberhagen. The concept is as simple as it is disturbing: the solution to the Fermi Paradox is that all intelligent life is wiped out by self-replicating machines—known as Von Neumann probes—that methodically sterilize the galaxy of intelligence.
All this talk of interstellar probes may seem outlandish, but there are a few things worth considering. First, our galaxy, across its 13-billion-year history, has likely spawned numerous advanced civilizations, many of which were (or are) capable of launching probes on interstellar missions. Secondly, we ourselves have already launched three interstellar (or interstellar-bound) probes as a result of exploring our immediate environment: both Voyager probes and New Horizons.
It's therefore not unreasonable to assume that interstellar probes of varying ages and technologies are zipping around the Milky Way. One day, we just might spot one of these alien artifacts passing through our neck of the celestial woods. Let's hope it's friendly.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Centauri Therapeutics Receives an Additional $5.1M from CARB-X to Progress ABX-01 Lead Compound to First in Human Clinical Trials
Centauri Therapeutics Receives an Additional $5.1M from CARB-X to Progress ABX-01 Lead Compound to First in Human Clinical Trials

Yahoo

time3 hours ago

  • Yahoo

Centauri Therapeutics Receives an Additional $5.1M from CARB-X to Progress ABX-01 Lead Compound to First in Human Clinical Trials

CARB-X provides an additional $5.1M to complete the non-clinical safety and efficacy studies with ABX-01 lead candidate Centauri plans the progression of lead candidate, an immunotherapy based broad-spectrum antimicrobial, to a first in human clinical study in early 2026 CARB-X's additional funding brings their financial support to date for the Alphamer platform and lead compound non-clinical development to $12.3M ALDERLEY PARK, England, July 29, 2025--(BUSINESS WIRE)--Centauri Therapeutics Limited ('Centauri' or 'the Company'), an immunotherapy company with a unique and proprietary platform technology applicable across a wide range of therapeutic indications, announced today that CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) has provided an additional $5.1M in funding for the development of their lead compound. The funds will contribute to the advancement of the lead candidate in Centauri's ABX-01 programme into first in human clinical studies, and this latest funding brings CARB-X's total support from 2019 to date to $12.3M. Centauri announced the selection of its first clinical candidate in the ABX-01 programme in March 20251. The candidate is a broad-spectrum antimicrobial specifically selected to combat clinically prevalent and multidrug-resistant bacterial strains. Based on the Company's proprietary Alphamer® platform, it is designed to target serious Gram-negative bacterial infections in the lung, expanding therapeutic options for the most vulnerable patients. It employs a dual mechanism of action, combining immunotherapeutic effects through complement fixation and phagocytosis with intrinsic antibacterial properties, within a single molecule. Early efficacy studies have demonstrated the compound's activity against Gram-negative bacteria. "The unwavering scientific and financial support from CARB-X has provided stability to Centauri as a company, expanded understanding of our Alphamer platform, and enabled us to progress the ABX-01 programme from discovery, through early development, and is now providing a smooth and continuous path towards First in Human clinical studies," said Dr. Jennifer Schneider, Chief Executive Officer, Centauri Therapeutics. "We are thankful for CARB-X and their continued engagement and confidence, which has allowed us to move a step closer to delivering a much needed therapeutic for serious, drug-resistant Gram-negative infections, even in the most clinically vulnerable patients." Dr. Erin Duffy, Chief of Research and Development, CARB-X, commented: "We have been proud to support Centauri, beginning with answering key questions on the approach and continuing with the drug discovery that has led to the lead asset of ABX-01 and its progression towards building a dossier to support its advancement into first in human clinical trials." CARB-X's funding for this project is provided in part with federal funds from the U.S. Department of Health and Human Services (HHS); Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority; under agreement number: 75A50122C00028, and by awards from Wellcome (WT224842), and Germany's Federal Ministry of Research, Technology and Space (BMFTR). The content of this press release is solely the responsibility of the authors and does not necessarily represent the official views of CARB-X or any of its funders. Press Release (4th March, 2025): Centauri Therapeutics selects first clinical candidate, for immunotherapeutic treatment of Gram-negative bacterial infections View source version on Contacts Media contact Katie OdgaardEmail: Tel: +44 (0) 7787 502 947 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

The nerve-zapping device that ‘could help improve your fitness'
The nerve-zapping device that ‘could help improve your fitness'

Yahoo

time10 hours ago

  • Yahoo

The nerve-zapping device that ‘could help improve your fitness'

A small device that zaps a major nerve connecting the heart and brain could help improve fitness, an early trial suggests. The device, clipped to the outer ear, sends gentle electrical pulses to increase the activity of the vagus nerve, which plays a key role in regulating heart function. Wearing the stimulator for just 30 minutes a day increased oxygen intake during exercise, according to researchers, who hope it could one day be used to help people who are not very active. The study, led by researchers at University College London and Queen Mary University of London, involved 28 healthy volunteers. Half were given the nerve stimulator to wear for 30 minutes every day for a week, while the other half were given a dummy device. Following a two-week break, the groups swapped devices. All of those taking part in the trial had an exercise test at the beginning and end of the week they wore the stimulator. The trial, published in the European Heart Journal, found those wearing the nerve stimulator were able to exercise more intensely than when wearing the dummy device. After a week, the stimulator increased oxygen intake during exercise by 4 per cent. It also boosted maximum breathing rate by an average of four breaths per minute, and maximum heart rate by four beats per minute during exercise. Gareth Ackland, a professor of perioperative medicine at Queen Mary University of London School of Medicine, said: 'Maintaining physical activity is essential for every aspect of cardiovascular, emotional, and cognitive health. 'The outcome of the trial is consistent with the significant body of evidence pointing to an important role of the brain in optimising exercise performance and regulating the activity of the immune system, helped by the vagus nerve'. Blood samples were also take from five people, with researchers suggesting wearing the nerve stimulator for a week helped reduce inflammation. Prof Ackland added: 'We will need to carry out larger trials to confirm our findings, but the results of this study in healthy volunteers suggest that increasing vagus nerve activity can improve fitness and reduce inflammation, potentially offering new approaches to improve heart health.' Professor Bryan Williams, chief scientific and medical officer at the British Heart Foundation, which funded the study, said: 'This early study suggests that a simple technology, which harnesses the connection between the heart and the brain, can lead to improvements in fitness and exercise tolerance. 'While more research is needed involving people with cardiovascular disease, this could one day be used as a tool to improve wellbeing and quality of life for people with heart failure.'

New study says self-test could prevent up to 1,000 cervical cancer cases a year
New study says self-test could prevent up to 1,000 cervical cancer cases a year

Yahoo

time12 hours ago

  • Yahoo

New study says self-test could prevent up to 1,000 cervical cancer cases a year

About a third of women are overdue for their appointment for life-saving cervical cancer screening – due to embarrassment, discomfort or simply not having enough time to attend. But offering women an at-home self-test could prevent as many as 1,000 cases of cervical cancer every year, a study led by Queen Mary University of London with King's College London found. More than 3,000 women are diagnosed with cervical cancer each year in the UK. It has been estimated that the number would be 5,000 higher if it weren't for cervical screening. The number of women participating in cervical screening has been falling, and in 2024, only 66 per cent of those eligible for screening were up to date. It tests for a virus called human papillomavirus (HPV), which can cause changes in the cervix and in some cases, can lead to cervical cancer. 'Cervical cancer is the most preventable of cancers. Women born before 1990 will not benefit from the HPV vaccination. But they can reduce their risk by 80 to 90 per cent if they get screened regularly,' Professor Peter Sasieni from Queen Mary University of London explained. In the study, published in the journal EClinicalMedicine, researchers recruited 13 GP practices in West London to find out the benefits of offering women a take-home test. These practices were divided into two groups, with about 6,000 women who were overdue for their screening in each group. One group of GP practices made in-person kit offers to women who were at least six months overdue for their cervical screening, the other group did not. For the first group, when women attended their GP practice for any reason, their doctor or nurse was encouraged to offer them a self-sampling kit. In the study, people who were 15 months overdue for cervical screening were randomised each month. Half received no special communication, a quarter were mailed a self-sampling kit, and a quarter were sent a letter offering a kit. Of the 449 women opportunistically offered a kit in a GP appointment, 234 (52 per cent) accepted and returned a sample. However, the uptake of self-sampling after a postal offer was lower: 12 per cent among those sent a kit, and just 5 per cent for women sent a letter offering a kit. Researchers estimate that if this approach were adopted across the NHS, 1,000 cases of cervical cancer could be prevented. Home-testing kits for HPV will soon be offered to people in England who are overdue for cervical cancer screening, giving women and people with a cervix the option to stay up to date with cervical screening without needing an internal examination. Dr Anita Lim, lead epidemiologist on the study from King's College London, said: 'These findings are directly relevant to current efforts to modernise cervical screening in England. Self-sampling gives women greater control over how and when they get screened. 'This study reinforces that many women welcome the option - particularly when it's offered in person by a trusted healthcare professional. A simple change like this could have a major impact on preventing cervical cancer.' There are about 100 types of HPV, and only 30 can affect the genital area. Many people never show symptoms as they can arise years after an infection, and the majority of cases go away without treatment. Vaccinating against HPV is almost 90 per cent effective at preventing cervical cancer in women in their twenties who were offered it at age 12 to 13, according to Cancer Research UK. But the best way to prevent cervical cancer in those not vaccinated when they were young is through screening, reducing the risk by 80 per cent. Fiona Osgun, head of health information at Cancer Research UK, said: "We know that almost a third of people in the UK tell us they are overdue their appointment - whether that's due to discomfort, embarrassment, or simply struggling for time. "That's why we welcomed the government's decision last month to roll out cervical home screening kits in England for people who don't take up their invite. This study shows that offering these kits during GP appointments could be part of an effective approach to making screening more accessible and remove barriers. "It's important to remember that cervical screening is for people without symptoms so, if you notice any unusual changes for you, don't wait for a screening invitation - speak to your doctor."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store